Background/Objectives: To investigate the relationship between body mass index (BMI) and mortality from various causes. Subjects/Methods: Data of 72 947 European men and 62 798 women aged 24-99 years at baseline were collaboratively analyzed. Both absolute and relative mortality risks were estimated within each BMI categories. The hazard ratio was estimated using Cox regression analysis adjusting for age, cohort and smoking status. Results: Over a median follow-up of 16.8 years, 29 071 participants died, 13 502 from cardiovascular disease (CVD) and 8748 from cancers of all types. All-cause and cancer mortality showed a U-shaped relationship: decreased first, leveled off, and then increased with increasing BMI with the lowest mortality risk approximately between 23.0 and 28.0 kg/m 2 of BMI in men and 21.0 and 28.0 kg/m 2 in women. The U-shaped relationship held for all-cause mortality but disappeared for cancer mortality among non-smokers. The CVD mortality was constant until a BMI of approximately 28.0 kg/m 2 and then increased gradually in both men and women, which was independent of age, cohort and smoking status. Conclusions: A U-shaped relationship of BMI with all-cause mortality but a graded relationship with CVD mortality at BMI 428.0 kg/m 2 was detected. The relationship between cancer mortality and BMI largely depended on smoking status, and need to be further investigated with site-specific cancers.
Introduction
Obesity had become the sixth most important risk factor contributing to the overall burden of various diseases worldwide (Ezzati et al., 2002) according to the World Health Organization 2002 report. It has been well recognized that obesity defined as having a body mass index (BMI) X30 kg/m 2 is associated with many diseases that contribute to premature death, such as cardiovascular disease (CVD), diabetes and certain types of cancers (Hubert et al., 1983; Colditz et al., 1990; Kurth et al., 2002; Calle et al., 2003; Batty et al., 2005; Nyamdorj et al., 2009) . However, the association of BMI with mortality of various causes is controversial: a positive (Lee et al., 1993) , a J-shaped (Manson et al., 1995; Calle et al., 1999; Moore et al., 2008) or U-shaped (Seidell et al., 1996; Shaper et al., 1997; Rosengren et al., 1999; Baik et al., 2000; Flegal et al., 2005; Breeze et al., 2006; Pischon et al., 2008; Klenk et al., 2009 ) relation with all-cause mortality; a positive (Lee et al., 1993; Seidell et al., 1996; Flegal et al., 2007; Kivimaki et al., 2008) or a J-shaped (Jonsson et al., 2002) relation with CVD mortality; a positive (Calle et al., 1999 (Calle et al., , 2003 Hu et al., 2004; Berrington de Gonzalez et al., 2010) , a J-shaped (Reeves et al., 2007) relation and no association (Baik et al., 2000; Meyer et al., 2002; Batty et al., 2005; Flegal et al., 2007) with cancer mortality have all been reported.
Recently, the World Health Organization definition for overweight has been questioned by several studies which showed that overweight (BMI between 25.0 and 30 kg/m 2 ) was not associated with increased risk of death (Flegal et al., 2005; McGee and Diverse Populations Collaboration, 2005; Lenz et al., 2009 ). The controversy between previous studies may be because of the differences in study design and study populations. To clarify the shape of the relationship of BMI with mortality of various causes may extend our understanding on the role of underweight, overweight and obesity in relation to the development of diseases and mortality of various causes, and could help to improve the definition of underweight and obesity. This is important considering the increase in the prevalence of obesity and its adverse health consequences worldwide. In the current study, the BMImortality relationship is investigated based on the data of the large Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe study.
Subjects and methods

Study population
Data were collected from 33 prospective studies in 11 European countries and the study population comprised 142 885 Europeans including 76 226 men and 66 659 women aged 24-99 at baseline. This involved the completion of a self-reported questionnaire on smoking and participation in a medical examination to measure body weight and height, described in detail in previous Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe publications (DECODE, 2001) . Participants with missing data on body weight and height (n ¼ 2588) and on smoking status (n ¼ 4490) were excluded. Subjects who had emigrated but the dates of the emigration were recorded were treated as censored cases. Individuals without exact date of emigration or completely lost to follow-up were also excluded (n ¼ 62). Thus, the final sample for this analysis included a total of 135 745 participants (72 947 men and 62 798 women) with a median follow-up of 16.8 years.
Individual participant data from each cohort was sent to the Diabetes Prevention Unit of the National Institute for Health and Welfare in Helsinki, Finland for collaborative data analyses. Each study was approved by the local ethics committees, and the analysis plan was approved by the ethics committee of the National Institute for Health and Welfare.
Definition of covariates BMI at baseline was calculated as body weight in kilograms divided by the square of height in meters. Smoking status at baseline was classified based on responses to the questionnaire into three categories of never smokers, current smokers and former smokers in most of the studies but not in all. The mortality risk of former smokers was checked against never and current smokers within each BMI category, and the results showed that the mortality risk among former smokers was similar to that of never smokers within each BMI category. In addition, the mean BMI of former smokers was similar to that of never smokers, both higher than that of current smokers. Thus, in the final data analysis, we combined never smokers with former smokers to form a currently non-smoking category to increase statistical power and to harmonize and standardize the smoking variables received from different studies.
Definition of fatal events
Vital status and cause of deaths were recorded in all of the studies included. CVD mortality was defined according to the International Classification of Disease codes 331, 420 (7th revision), 401-448 (8th or 9th revision) and codes I10-I79 (10th revision). Cancer mortality was defined as cancers of all types by the International Classification of Disease codes 158, 162, 181, 193, 199, 200, 204 (7th revision) , 140-239 (8th or 9th revision) and codes C00-C97, D00-D09 (10th revision).
Statistical analysis
Participants were classified into the following 18 BMI categories of o19. 0, 19.0-19.9, 20.0-20.9, 21.0-21.9, 22.0-22.9, 23.0-23.9, 24.0-24.9, 25.0-25.9, 26.0-26.9, 27.0-27.9, 28.0-28.9, 29.0-29.9, 30.0-30.9, 31.0-31.9, 32.0-32.9, 33.0-33.9, 34.0-34.9 and X35.0 kg/m 2 . Crude mortality was calculated and plotted for each BMI category. The category with the lowest mortality rate was chosen as the reference category to estimate the relative risk or hazard ratio (HR) using Cox proportional hazards models adjusting for age, cohort and smoking status. A sensitivity analysis by excluding the participants who died in the first 5-year follow-up was performed to assess the reverse causation. Because current smokers were leaner and had increased mortality compared with current non-smokers in this study, a further analysis was performed stratified by current smoking status using nine BMI categories of o19. 0, 19.0-21.0, 21.0-23.0, 23.0-25.0, 25.0-27.0, 27.0-29.0, 29.0-31.0, 31.0-33 .0 and X33.0 kg/m 2 to explore to what extent smoking has contributed to the increased mortality in the low BMI categories. The formal interaction between smoking status and the BMI categories was also tested. In addition, we performed analyses for competing risks using STATA 11.0 (Stata Corp., College Station, TX, USA) to estimate the probability of the CVD mortality in the presence of competing risk of cancer mortality or vice versa.
Results
Baseline characteristics of the cohorts are presented in Table 1 . Over a median follow-up of 16.8 years, 29 071 participants died, 13 502 from CVD and 8748 from cancers. Old age was associated with both CVD and cancer mortality (Table 2) . Current smoking was associated with cancer mortality in both genders and with CVD mortality in men but not in women. Mean BMI was significantly higher in individuals who died of CVD but not in those who died of cancers compared with those who were still alive.
Crude mortality rates per 1000 person-years and HRs (95% confidence intervals) for mortality from various causes adjusted for age, cohort and further adjusted for smoking status are shown in Figure 1 and online Tables 1-2. All-cause and cancer mortality decreased first, leveled off, and then increased with increasing BMI levels (kg/m Tables 1-2) . Adjustment for smoking status lowered the HRs in the lower BMI categories but increased the HRs associated with higher BMI levels ( Figure 1 ). Smokers tended to have low BMI (Table 3) . The smoking-BMI interaction was significant for mortality from various causes in both men and women. Our analysis stratified by smoking status showed that among non-smokers the U-shaped relationship between BMI and all-cause mortality held, but it disappeared for cancer mortality. CVD mortality increased gradually at the upper BMI distribution among non-smokers. Among current smokers, the HRs for mortality of various causes were constantly higher across the entire range of BMI than nonsmokers within the same BMI category. Because the deaths from CVD and cancers are mutually exclusive, a competing risk analysis was also performed which did not alter the observed relationship between BMI and mortality of CVD and cancers (Supplementary Tables 1-2) .
Discussion
In this European population, a U-shaped relationship between BMI and mortality from all-cause and from all cancers was observed; however, the increased risk associated with low BMI disappeared for cancer mortality among nonsmokers. Mortality from CVD increased positively with increasing BMI levels at the upper BMI distribution, which was independent of smoking status.
Almost all studies investigating all-cause mortality have found significantly increased risk at both the lower and the upper ends of the BMI distributions, with constant lower risk of mortality in the middle of the BMI distribution (Manson et al., 1995; Seidell et al., 1996; Calle et al., 1999; Rosengren et al., 1999; Flegal et al., 2005; Breeze et al., 2006; Kivimaki et al., 2008; Moore et al., 2008; Klenk et al., 2009; Prospective Studies Collaboration et al., 2009) . Thus, these studies claimed a J-or a U-shaped relationship of BMI with all-cause mortality, but the ideal BMI range where the mortality risk was low has not been consistently defined partly because of the differences in BMI classifications, methods used to estimate mortality risk and partly by different smoking rates within different populations. There was, however, one study reporting a positive relationship between all-cause mortality and BMI in men (Lee et al., 1993) , without any excess mortality among lean individuals (BMIo22.5 kg/m 2 ). It worth to mention that the BMI cutoff to define 'lean' was set higher in this study compared with ours that might obscure a risk increase at low BMI levels. As shown in the Table 3 , more current smokers than non-smokers had a low BMI category, and smoking has largely contributed to the high mortality risk observed in the lean individuals. This is consistent with a previous study by Lawlor et al. (2006) . (Calle et al., 1999 (Calle et al., , 2003 Hu et al., 2004; Berrington de Gonzalez et al., 2010) , or no relationship (Seidell et al., 1996; Baik et al., 2000; Meyer et al., 2002; Batty et al., 2005; Flegal et al., 2007) between BMI and cancer mortality. We found a vague U-shaped relationship between BMI and cancer mortality that confirmed the findings of Reeves et al. (2007) . Stratified analysis by smoking status, however, revealed that the high cancer mortality in lean individuals was mainly attributable to smoking. As shown in our study, current smokers were more commonly found in the low BMI categories compared with non-smokers in both genders. Further investigations are required to study site-specific cancer mortality in men and women.
This study was based on data from large European population-or occupational-based studies and should be representative of the general population. Thus, a large number of middle-aged and elderly European men and women followed for a median 16.8 years led to a relatively large number of deaths from all causes, CVD and cancers that gave power to investigate the association between BMI and risk of mortality with small BMI intervals. Po0.05 for differences between yes and no.
Data are cohort-and age-adjusted mean (standard error) or as noted.
A relative limitation of the study is the lack of information on weight changes before the study, that makes it impossible to exclude the 'reverse causation' possibility, which is inherently existing in any study of mortality (Willett et al., 1999) because the weight changes before the baseline examination could be a consequence of underlying diseases before enrolment rather than a cause of deaths. However, after excluding the deaths arisen within the first 5-year follow-up, the results were not changed substantially. Another limitation of the study is that no information on physical activity (a potential confounder in our analysis) at baseline is available, furthermore physical activity and fitness is an independent predictor of death and the effect of obesity on morbidity and mortality could be largely diminished by higher levels of physical fitness (Hu et al., 2004) . Nevertheless, the effect of physical activity on longevity is still controversial and needs further investigation. Other potential confounders were also unavailable such as menopause status at baseline and body composition that could be very different between men and women and changes with menopause (Poehlman et al., 1995; Hoover and Boote, 2000) .
In spite of a decrease in mortality, BMI has increased slightly during the last three decades in Europe (Flegal et al., 2002; Hedley et al., 2004; Vartiainen et al., 2010) that might suggest that cohort effects may have a role in our findings; however, the increase in BMI in the current study is too small to substantially affect the results (mean BMI 25.6 kg/m 2 in the 1970s, 25.6 kg/m 2 in the 1980s and 26.3 kg/m 2 in the 1990s). The shift of the BMI distribution toward the right in the general population can increase the risk of obesity-related disorders, such as diabetes and CVD, but its direct impact on mortality is not straight forward, as mortality is a complex outcome of many factors including occurrence of a disease and its treatment. Therefore, obesity defined by BMI maybe a useful indicator for intervention for diabetes and CVD, but a poor measure of mortality from all-causes and certain cancers. Considering the complex underlying causes of cancer deaths and the vague relationship found in our study, further investigations are required to study site-specific cancer mortality.
In conclusion, a U-shaped relationship between BMI and mortality from all-cause and from cancer was observed, but the relationship disappeared for cancer mortality among non-smokers. Mortality from CVD increased positively with increasing BMI levels at the upper BMI distribution, which was independent of smoking status. 
